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Short summary 
 
To date, the International Committee for Taxonomy of Viruses recognizes that the family Arenaviridae 
contains a unique genus Arenavirus that includes 22 viral species. There are 9 additional arenaviruses 
that either have been discovered recently, or which taxonomic status remains pending. Arenaviruses 
have been classified according to their antigenic properties into two groups, the Lassa-Lymphocytic 
choriomeningitis (LCM) serocomplex and the Tacaribe serocomplex which has been further divided into 
four evolutionary lineages. Each arenavirus is more or less tightly associated with a mammal host. The 
distribution of the host dictates the distribution of the virus. Humans may become infected by 
arenaviruses through direct contact with infected rodents, including bites, or through inhalation of 
infectious rodent excreta and secreta. Lassa, Junin, Machupo, Guanarito, and Sabia viruses are known 
to cause a severe hemorrhagic fever, in western Africa, Argentina, Bolivia, Venezuela, and Brazil, 
respectively. Infection by LCM virus can result in acute central nervous system disease, congenital 
malformations, and infection in organ transplantation recipients. Detection of arenaviruses in their 
animal host can be achieved by virus isolation, and has recently taken advantage of PCR-based 
techniques. The approach based on consensus degenerate primers has shown efficient for both 
detection of known arenaviruses, and discovery of new arenaviruses. 
 
Introduction 
 
The eight edition of the Report of the International Committee for Taxonomy of Viruses (ICTV) states 
that the family Arenaviridae contains a unique genus Arenavirus that includes 22 viral species (Salvato 
et al., 2005). New arenaviruses were discovered recently and will be discussed (Table). Virions are 
spherical to pleomorphic with a diameter of 50–300 nm (average diameter for spherical particles is 120 
nm). They possess a dense lipid-containing envelope proteins covered with 8-10 nm long club-shaped 
projections. Ribosomes (20-25 nm) may be present in the viral particles, and are responsible for their 
sandy appearance when viewed by electron microscopy, hence the name arenavirus (arena: sand, 
Latin). Arenaviruses are enveloped single-stranded RNA viruses, with a genome consisting of two RNA 
segments, designated large (L) and small (S). Each RNA segment encodes 2 non-overlapping reading 
frames of opposite orientations. The S RNA segment (~3,400 nucleotides) encodes the structural 
nucleoprotein, and the glycoprotein precursor secondarily cleaved into the envelope proteins G1 and 
G2. The L RNA segment (~7,200 nucleotides) encodes the viral polymerase and the Z protein, a zinc-
binding matrix protein. The genes on both S and L segments are separated by an intergenic non coding 
region with the potential of forming one or more hairpin configurations. The 5' and 3' untranslated 
terminal sequences of each RNA segment possess a relatively conserved reverse complementary 
sequence spanning 19 nucleotides at each extremity. 
The arenaviruses have been classified according to their antigenic properties into two groups: the 
Tacaribe serocomplex (including viruses indigenous to the New world) and the Lassa-Lymphocytic 
choriomeningitis serocomplex (including the viruses indigenous to Africa and the ubiquitous lymphocytic 
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choriomeningitis virus (LCMV), recognized as the Old world group) (Salvato et al., 2005). Nucleocapsid 
antigens are shared by most arenaviruses, and quantitative relationships show the basic split between 
African viruses and those in the Western Hemisphere. Individual viruses are immunologically distinct by 
neutralization assays, which depend on the specificity of epitopes contained in the envelope 
glycoproteins (Salvato et al., 2005). Each virus species is more or less tightly associated with a rodent 
species (the only exception known at this time is Tacaribe virus which is associated with a species of 
bat) (Childs & Peters, 1993). Accordingly the distribution of the host dictates the distribution of the 
virus. LCMV is the only arenavirus to exhibit a worldwide distribution due to its association with Mus 
musculus. Other arenaviruses are distributed either in the New World or in Africa. 
 
History 
 
The family prototype, LCMV, was first isolated in 1933 during serial passage in monkeys of human 
material obtained from a fatal infection in the first documented epidemic of St. Louis encephalitis 
(Armstrong and Lillie, 1934). Lassa, Junin, Machupo, Guanarito, and Sabia viruses are known to 
cause a severe hemorrhagic fever, in western Africa, Argentina, Bolivia, Venezuela, and Brazil, 
respectively (Peters et al., 1996), and were first recovered during investigations of outbreaks in 1958 
(Parodi et al.,1958), in 1963 (Johnson et al., 1965), 1969 (Buckley et al., 1970), 1989 (Salas et al., 
1991), and of a single case in 1990 (Lisieux et al., 1994), respectively. They are included in the 
Category A Pathogen List as defined by the CDC, and listed as Biosafety Level 4 (BSL-4) agents. 
LCMV, Lassa, and related viruses from the Old World are associated with rodents from the family 
Muridae, subfamily Murinae. New World arenaviruses are associated with New World rodents in the 
family Muridae, subfamily Sigmodontinae (Wilson and Reeder, 2005). The relative correspondence 
between the phylogeny of the hosts and of the viruses has suggested a long association also known as 
cospeciation or coevolution with rodents (Gonzalez et al., 1986, Bowen et al., 1997). However, this 
concept remains controversial due to the limited information in terms of dating the phenomenon and 
understanding the mechanisms involved.  For example rates of evolution estimated for LCMV appear to 
contradict estimated evolution rates of viruses and rodents by several orders of magnitude. Moreover, 
Tacaribe virus has been isolated from bats, not rodents, and is not known to be a chronic, inapparent 
infection of rodents.  
 
Newly discovered arenaviruses 
 
Chapare virus was recently isolated from a unique fatal human case of hemorrhagic fever in the 
Chapare River region close to Cochabamba in Bolivia (Delgado et al., 2008). There is currently no 
information concerning the rodent host of Chapare virus.  
Morogoro virus was isolated from Mastomys sp trapped in Tanzania (Vieth et al., 2007). This virus is 
most closely related to Mopeia virus regardless of the gene used for analysis (Charrel et al., 2008).  
Dandenong virus was identified via a metagenomic approach, and subsequently isolated from tissue 
specimens collected from a fatal case of infection in a patient who underwent kidney transplantation in 
Australia from a donor who spent a 3-month visit in the former Yugoslavia, where he had traveled in 
rural areas (Palacios et al., 2008). Genetic distance analyses suggested that the taxonomic status of 
Dandenong virus requires additional investigations for its resolution.  
For Catarina, Skinner Tank, Tonto Creek and Big Brushy Tank viruses, recently discovered in the 
United States of America, complete sequences are only available for the NP and GPC genes at present 
(Cajimat et al., 2007; Cajimat et al., 2008; Milazzo et al., 2008). Their taxonomic classification is 
currently under investigation at the ICTV. These four viruses were isolated from Neotoma rodents. They 
appear most closely related to Whitewater Arroyo virus. As in the case of their close relatives, North 
American Whitewater Arroyo, Tamiami, and Bear Canyon virus, they demonstrate a discrepant grouping 
with clade A and clade B viruses depending on which structural protein (NP or signal peptide/G2) is 
used for analysis. This suggests that these seven viruses are derived from a common ancestor. 
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Kodoko virus was detected, but not isolated, in tissues of Mus Nannomys minutoides trapped in Guinea. 
Partial sequence analysis indicates that Kodoko virus roots LCMV (Lecompte et al., 2007). This partial 
information tends to support the consideration of Kodoko virus as a new species. However, this must be 
confirmed by virus isolation, complete genome sequencing and identification of the natural host. 
Partial sequences of Pinhal virus (Calomys tener from Brazil) NP protein were obtained from Genbank 
with minimal information. Using these partial NP sequences for comparison, Pinhal virus is most closely 
related to Oliveros virus (19-20%) (Charrel et al., 2008). 
 
 
Evolutionary relationships 
 
Genetic studies recently revealed congruency with serological delineation (Figure). Phylogenetic 
analyses were historically based on sequence representing a partial region of the NP gene (Bowen et 
al., 1996; Bowen et al., 1997). The genus was divided into two main groups corresponding to the Old 
World and the New World viruses. The Old World (Lassa-LCM serocomplex) lineage comprises seven 
viruses: LCM, Lassa, Mopeia, Mobala, Ippy, Morogoro and Kodoko and is distantly rooted to the three 
New World (Tacaribe serocomplex) lineages, designated A, B, and C. Lineage A includes five South 
American viruses, Pirital, Pichinde, Flexal, Parana, Allpahuayo. Lineage B includes eight South 
American viruses including Sabia, Junin, Machupo, Guanarito, Amapari, Tacaribe, Cupixi and Chapare 
viruses. Lineage C comprises two South American viruses: Oliveros and Latino. Phylogenetic studies 
conducted with complete S RNA sequences recently demonstrated that discrepancies observed in the 
topology of phylograms reconstructed from nucleoprotein and glycoprotein genes are attributed to the 
recombinant nature of the S RNA segment of the three North American viruses: Whitewater Arroyo, 
Tamiami, and Bear Canyon (Charrel et al., 2002; Charrel et al., 2003). The recent discovery of 
additional North American arenaviruses, Skinner Tank, Catarina, Tonto Creek and Big Brushy Tank 
viruses (isolated from Neotoma rodents) confirmed this finding (Cajimat et al., 2007; Cajimat et al., 
2008; Milazzo et al., 2008), and indicated that these 2 viruses underwent the same evolutionary 
mechanism (Figure).  
 
Phylogenetic analyses were progressively updated with the availability of complete sequences for the L 
RNA segment. The most comprehensive study, based on the comparative analysis of complete 
sequences of the four genes for the largest set of viruses, was published recently (Charrel et al., 2008). 
The delineation into an Old World group and a New World group, which was subsequently divided into 
three clades corresponding to the antigenic findings, was confirmed. Comparative analysis of the NP 
and GPC sequences showed that the discrepant position observed in the two genomic regions 
respectively for the viruses indigenous to North America (Tamiami, Whitewater Arroyo, Bear Canyon, 
and the more recently discovered Skinner Tank, Catarina, Tonto Creek and Big Brushy Tank viruses is 
due to the recombinant nature of the S RNA segment of these viruses, as reported previously (Charrel 
et al., 2001). No recombination was observed in the L RNA segment. From this dataset and analysis, it 
appeared that no arenavirus genome was the result of a reassortment (also known as intersegmental 
recombination) mechanism. 
 
 
Disease in animals and man, therapy and diagnostic 
 
Humans may become infected by arenaviruses through direct contact with infected rodents, including 
bites, or through inhalation of infectious rodent excreta and secreta. The domestic and peridomestic 
behavior of several species of rodent reservoir hosts is a major contributing factor facilitating viral 
transmission from rodent to human. However, in most cases, transmission of arenaviruses to humans 
occurs following recreational or agricultural incursions into environments providing critical habitat for 
rodent hosts. Additionally, professionals handling infected rodents in the field or laboratory are at 
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increased risk of infection (Sewell, 1995). Mostly, modifications of the environment due either to human 
activities (modern farming practices), or natural ecological changes (flooding, storms) have been 
implicated in the emergence of human disease caused by arenaviruses resulting from changes in 
behaviour of the reservoir host. 
 
To date, 7 arenaviruses are associated with human disease with different clinical pictures. Lassa, Junin, 
Machupo, Guanarito, Sabia and Chapare viruses are known to cause a severe hemorrhagic fever, in 
western Africa, Argentina, Bolivia, Venezuela, Brazil, and Bolivia respectively (Peters et al., 1996; Delgado 
et al., 2008). Infection by LCM virus can result in acute central nervous system disease and congenital 
malformations (Barton and Hyndman, 2000; Barton et al., 1993); it has recently been described as an 
important cause of fatal infection in organ transplantation recipients, and immunocompetent patients (CDC, 
2005; Fischer et al., 2006; Amman et al., 2007; Charrel et al., 2006; Emonet et al., 2007, Palacios et 
al., 2008). Very little is known about the health consequences of infection with the other arenaviruses. 
Flexal and Tacaribe viruses have caused febrile illness in laboratory workers (Peters et al., 1996). 
Whitewater Arroyo virus may have been associated with 3 fatal cases of infection in California (CDC, 2000). 
Exposure to Pichinde virus has resulted in numerous seroconversions among humans without any 
noticeable clinical significance (Buchmeier, unpublished results). Tacaribe virus is believed to have 
caused a single case of a febrile disease with mild CNS symptomatology (J. Casals, unpublished data). 
 
A live attenuated Junin virus vaccine (Candid#1) was produced. Its efficacy was proven in a double-
blind trial in 15,000 agricultural workers at risk to natural infection in Argentina. Subsequently, more than 
100,000 people were immunized in Argentina. A prospective study conducted over two epidemic 
seasons among 6,500 male agricultural workers in Argentina showed that Candid #1 vaccine efficacy 
was greater or equal to 84%, and no serious adverse effects were detected (Maiztegui et al., 1998).  
Development of Lassa virus vaccine was attempted during the last 30 
years. The most advanced projects include (i) a replication-
competent vaccine based on attenuated recombinant vesicular 
stomatitis virus vectors expressing the Lassa viral glycoprotein 
showed that a single intramuscular vaccination elicited a protective 
immune response in nonhuman primates against a lethal challenge 
(Geisbert et al., 2005); (ii) ML29, a recombinant Lassa/Mopeia virus 
vaccine which replication is attenuated in guinea pigs and nonhuman primates, and demonstrated 
protection against Lassa virus challenge in guinea pigs, Rhesus macaques (Lukashevich et al., 2008); 
(iii) a yellow fever 17D vaccine expressing Lassa virus glycoprotein precursor protected guinea pigs 
against fatal Lassa fever (Bredenbeek et al., 2006). 
Recently, a recombinant LCMV/Vesiculovirus vaccine which is attenuated, prevents lethal challenge 
with LCMV in mice, elicits rapid and long-lived cell-mediated immunity against lethal challenge with wild-
type LCMV, confers rapid and long-lived cell-mediated protection against overwhelming systemic 
infection and liver disease, presents no detectable gain in pathogenicity after propagation in 
immunodeficient hosts (Bergthaler et al., 2007). 
 
Antivirals  
No antiviral is approved and commercialy available for arenaviruses, except for ribavirin, which proved 
to be efficient if treatment was administered at the early stage of Lassa fever (McCormick et al., 1986). 
There is however an intense activity centered on molecules with potential antiviral activity against 
arenaviruses. To date, the most promising molecules are those which interfere with the membrane 
fusion through the interaction of the G2 fusion subunit with the signal peptide due to IC50 below 10nM 
(Larson et al., 2008; York et al., 2008). 
 
 
Immune plasma therapy 
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For Junin virus infection, immune plasma therapy at an early stage showed efficient by reducing the 
mortality rate from 30% to 1% (Maiztegui et al., 1979). 
 
 
Diagnostics and detection of arenaviruses in clinical and environmental samples 
 
In the animal reservoir, detection of antibodies specific for arenaviruses is poorly indicative since they 
do not systematically correlate with the presence or absence of live virus. Depending on the virus, the 
mode, and age at the time of infection, the mammalian host may be persistently infected regardless of 
the presence or absence of antibodies.  Alternatively, an efficient immune response may result in the 
eradication of the virus. Therefore, serology can be indicative of the circulation of arenaviruses for a 
given population in a specific region, and thus can be used as an indicator for further investigation of 
virus circulation by molecular means. Therefore, the following paragraph will focus on the molecular 
methods that can be used to detect arenaviruses in animal samples. 
 
The detection of arenaviruses in animal specimens can be achieved by techniques based on consensus 
primer sequences or by assays that target specifically one virus. The latter require good knowledge of 
the genetic heterogeneity within a given species in order to avoid false negative results due to 
unaddressed mismatches in the primers or probes. Therefore, in the absence of this knowledge for most 
species, the consensus primer approach is preferred. Moreover, the frequent circulation of two or more 
arenaviruses in the same geographic region has encouraged the development of assays that amplify all 
recognized arenaviruses by combination of degenerate primers located in the conserved regions of the 
genome (Lozano et al., 1997; Bowen et al., 1996).  However, there are no reports of the use of these 
strategies in practical situations. A few years ago, the diagnostic strategy based on degenerate primers 
was hampered by the lack of genomic data in regions other than the nucleoprotein gene (Bowen et al., 
1996; Bowen et al., 1997). Nowadays, complete sequence data have been made available for all 
arenaviruses. However, degenerate primer strategies have not been fully reevaluated in light of these 
new data. This needs to be accomplished to enable identification of alternative genomic regions that can 
reveal relationships between both identified and as yet unidentified arenaviruses in human and animal 
samples. Recent discoveries of novel arenaviruses relied on the use of primers, broadly reactive for 
viruses within the genus, located in the L RNA segment. Kodoko virus and Morogoro virus were 
identified by using such an approach (Lecompte et al., 2007; Vieth et al., 2007). Recent advances in 
high-throughput methods, based on pyrosequencing technology, have proven to be efficient at 
identifying a novel arenavirus in clinical samples with no previous evidence of the presence of this virus 
(Palacios et al., 2008). 
As described above, the limited amount of knowledge on genetic diversity with a given species should 
be taken into account when designing diagnostic assays intended to detect specifically one arenavirus. 
For instance, new strains of LCMV were shown to be sufficiently divergent to hamper detection by the 
Taqman probe, due to mismatches. In the paper from McCausland et al, the two primers described for a 
real-time RT-PCR assay using the SybrGreen technology presented respectively 6 and 6 mismatches 
when aligned against an alignment of 6 LCMV strains (Armstrong, WE, CH, Traub, Pasteur, 
Marseille)(McCausland et al., 2008). Based on the same alignment, the four primers designed by 
McIver et al showed up to 6 mismatches in the sequence, and 6 mismatches in the TaqMan probe; such 
rates of mismatch will undoubtedly have a negative impact on the detection of LCMV RNA in clinical or 
environmental samples (McIver et al., 2005). To date, the assay described in Emonet et al (2007) 
based on SybrGreen technology is the only one to use primers designed to match all 6 previously listed 
sequences of LCMV (Emonet et al., 2007). However, it has been inadequately evaluated, and merits 
further investigation to determine its sensitivity and specificity. Such evaluation will be rendered 
necessary whenever a new strain of LCMV is isolated and sequenced. To date, there is insufficient 
knowledge of genetic heterogeneity within the species LCMV. Accordingly, it is advocated to combine 
the two approaches. 
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RT-PCR is to date the only method available for rapid diagnosis of Junin virus infection. For these 
reasons, several RT-PCR assays have been developed (Lozano et al., 1995; Lozano et al., 1993; 
Bockstahler et al., 1992). However, these techniques have never been employed practically in an 
epidemic situation to manage the outbreak, or more specifically to detect Junin virus infection at an early 
stage in order to initiate the immune plasma therapy that reduced the mortality rate from 30% to 1% 
(Maiztegui et al., 1979). More recently, a real time RT-PCR assay, with a 0.5 TCID50 detection limit, has 
been reported (Vieth et al., 2005). However, it has not been used in a clinical or environmental 
situation. In the same study, an assay specific for Guanarito virus was designed and detected 5 TCID50.  
 
Lassa virus is also a prominent threat outside the area of endemicity with several imported cases in 
Europe (Gunther et al., 2000; Cummins, 1990; Van der Heide et al., 1982), Japan (Hirabayashi et 
al., 1988), the United States (Holmes et al., 1990), and the Middle East (Schlaeffer et al., 1988). RT-
PCR diagnostic assays have been developed but never used for the early detection of human cases in 
epidemic situations in Africa (Demby et al., 1994; Trappier et al., 1993; Lukenheimer et al., 1990). 
More recently, a previously reported PCR assay was adapted to the real-time SybrGreen format and 
was tested with patient samples (Drosten et al., 2002); the detection limit was evaluated at 2245 
genome-equivalent per ml of serum whilst the viral load in patients is generally very high (> 105 
genome-equivalent per ml of serum). This assay has been compared to an L-assay based on 7 human 
specimens, and both tests showed a similar detection rate (Vieth et al., 2007). The first quality 
assurance study on the rapid detection of Lassa virus RNA included 24 participant laboratories from 17 
countries; tenfold dilutions of Lassa virus inactivated genetic material were detected at a rate varying 
from 21 to 85% depending on the concentration in the sample (Niedrig et al., 2004). Of interest is the 
fact that specimens containing high concentrations of viral RNA may produce false negative results due 
to inhibition of the enzymatic reactions. To date there is no study addressing the presence and 
prevalence of RT and PCR inhibitors depending on the organ used for analysis. This would be of utmost 
interest to deploy a strategy adapted to virus search. Meanwhile, it is therefore proposed that clinical 
specimens should be “spiked” with an internal control positive sample to monitor enzymatic reaction 
efficacy. Alternatively the test samples should be serially diluted to alleviate the problem of inhibition of 
enzymatic reactions in mammalian tissues. This point is pivotal to avoid underestimation of virus 
prevalence due to technical artifacts.  
 
 
Conclusions and future prospects 
 
During the last 3 years, the discovery of 9 new arenaviruses, of which 2 were human pathogens, 
strongly suggests that many more arenaviruses may be discovered in the future.  As new technologies 
begin to impact on virus discovery it is now becoming clear that a large number of viruses remain to be 
unearthed as recently suggested (Pybus et al., 2002). As illustrated above, the quest for new 
arenaviruses requires the combination of traditional virological approaches with innovative technologies 
such as large scale sequencing and extensive bioinformatic capacities. 
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Legends 
 
Table 
List of arenavirus species and newly discovered arenavirus not yet classified, and respective 
characteristics. 
 
 
Figure 
Phylogenetic relationships between arenaviruses within evolutionary lineages. Red, Old world viruses; 
Green, lineage A new world viruses, Blue, lineage B new world viruses; Grey, lineage C new world 
viruses; Purple, recombinant new world viruses. Left panel, phylogram based on nucleoprotein amino 
acid sequences, right panel, phylogram based on concatenated signal peptide and glycoprotein 2 amino 
acid sequences. The neighbor-joining, poisson and bootstrapping (200 pseudoreplications) algorithms 
were computed by MEGA 2 software package. 
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Table 1. List of arenaviruses.
virus acronym lineage country (possible) host BSL S RNA L RNA
Number of
complete(partial)
sequences**
Number of
complete(partial)
sequences
Allpahuayo ALLV NW-A Peru Oecomys bicolor, Oecomys paricola 2 2(0) 1(0)
Amapari AMAV NW-B Brazil Oryzomys goeldi, Neacomys guianae 2 1(0) 1(0)
Bear Canyon BCNV NW-Rec USA Peromyscus californicus, Neotoma macrotis 2 3(4) 2(0)
Catarina na NW-Rec USA Neotoma micropus 2 2(0) 0(0)
Chapare na NW-B Bolivia unknown NC 1(0) 1(0)
Cupixi CPXV NW-B Brazil Oryzomys capito 2 1(0) 1(0)
Dandenong na OW Australia Unknown NC 1(0) 1(0)
Flexal FLEV NW-A Brazil Oryzomys spp 3 2(0) 1(0)
Guanarito GTOV NW-B Venezuela Zygodontomys brevicauda, Sigmodon alstoni 4 2(33) 1(12)
Ippy IPPYV OW Central African Republic Arvicanthus spp 2 1(0) 1(0)
Junin JUNV NW-B Argentina Callomys musculinus 4 5(83) 5(1)
Kodoko na OW Guinea Mus Nannomys minutoides NC 0(2) 0(2)
Lassa LASV OW West Africa Mastomys natalensis 4 11(95) 6(11)
Latino LATV NW-C Bolivia Callomys callosus 2 1(0) 1(0)
LCM* LCMV OW ubiquitous Mus musculus, M domesticus 2/3 9(25) 8(5)
Machupo MACV NW-B Bolivia Callomys callosus 4 9(20) 3(8)
Mobala MOBV OW Central African Republic Praomys spp. 2 1(3) 1(2)
Mopeia MOPV OW Mozambique, Zimbabwe Mastomys natalensis 2 3(0) 2(1)
Morogoro na OW Tanzania Mastomys sp. NC 0(0) 0(0)
Oliveros OLVV NW-C Argentina Bolomys spp 2 1(0) 1(0)
Pampa na NW-C Argentina Bolomys spp 2 0(1) 0(0)
Parana PARV NW-A Paraguay Oryzomys buccinatus 2 1(0) 1(0)
Pichinde PICV NW-A Colombia Oryzomys albigularis 2 3(2) 3(0)
Pinhal na NW-C Brazil Calomys tener NC 0(5) 0(0)
Pirital PIRV NW-A Venezuela Sigmodon alstoni 2 1(28) 1(4)
Sabia SABV NW-B Brazil unknown 4 1(0) 1(0)
Skinner Tank na NW-Rec USA Neotoma mexicana NC 1(0) 0(0)
Tonto Creek na NW-Rec Neotoma spp. NC 0(0) 0(0)
Tacaribe TCRV NW-B Trinidad Artibeus bat 2 1(0) 1(0)
Tamiami TAMV NW-Rec USA Sigmodon hispidus 3 1(0) 1(0)
Whitewater Arroyo WWAV NW-Rec USA Neotoma spp. 2 5(11) 1(0)
*, Lymphocytic choriomeningitis virus, ** available in Genbank in December 2008.
Table 1
